Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000816023 | SCV000956511 | pathogenic | PMM2-congenital disorder of glycosylation | 2018-07-20 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in PMM2 are known to be pathogenic (PMID: 19862844). This variant has not been reported in the literature in individuals with PMM2-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ala19Profs*17) in the PMM2 gene. It is expected to result in an absent or disrupted protein product. |
Baylor Genetics | RCV000816023 | SCV004205324 | likely pathogenic | PMM2-congenital disorder of glycosylation | 2022-02-18 | criteria provided, single submitter | clinical testing |